Exhibit 99

                    PHC, INC. ANNOUNCES FINANCIAL RESULTS FOR
                          THIRD QUARTER OF FISCAL 2004


FOR IMMEDIATE RELEASE

Company Contact:                         Investor Relations Contact:
PHC, Inc.                                Hayden Communications, Inc.
Bruce A. Shear                           Matthew Hayden
978-536-2777                             843-272-4653

>>       3rd quarter revenues increase 10% compared to third quarter of 2003
>>       Research activities reorganized under Pivotal Research Centers name

Peabody,  MA, May 13, 2004 -- PHC, Inc., d.b.a.  Pioneer  Behavioral Health (OTC
Bulletin Board: PIHC), a leading provider of inpatient and outpatient behavioral
health  services,  today announced  financial  results for the third quarter and
nine-month  period  ended  March 31,  2004.  The  results  for the  quarter  and
nine-month period do not include the results from Pivotal Research Centers,  the
operations  of which  Pioneer  acquired  in April,  2004.  The  results  include
$947,500 in one-time  expenses  related to the  acquisition of Pivotal,  and the
disposition  of a lawsuit the  Company  inherited  from a previous  acquisition.
Without  these one time  expenses the Company  would have  reported an operating
profit for both reporting periods.

Revenues  for the third  quarter  increased  10 percent to $6.5 million from the
$5.9  million  reported in the fiscal  third  quarter of 2003.  Revenue from the
Company's  Wellplace  division  increased 86 percent to $733,411  from  $393,328
reported for the third quarter of last year.  This increase in revenue is due to
the start of the  Michigan  call  center  contract in March 2003 and the smoking
cessation  contract for the State of Kansas,  which began in July 2003. Net loss
applicable to common  shareholders  for the quarter,  which includes a number of
one time expenses,  was $845,265,  or $0.06 per diluted  share,  compared to net
income of $130,811, or $0.01 per diluted share reported in the year ago period.

Revenues for the  nine-month  period ended March 31, 2004 increased nine percent
to $19.1  million from $17.5  million for the  comparable  nine-month  period in
fiscal 2003. Net loss applicable to common  shareholders for the nine months was
$789,457,  or $0.06 per  diluted  share,  compared  to net income of $797,956 or
$0.05 per diluted share in the comparable period last year.

The one-time  expenses  related to the settlement and interest  expense  totaled
$947,500.  Exclusive of these one-time  events,  the Company would have reported
net income for the quarter of $102,235, or $0.01 per share.

"The events which transpired this quarter were necessary to properly position us
for both  near and  long-term  success,"  commented  Bruce A.  Shear,  Pioneer's
chairman and chief executive.  "We have successfully  financed and completed the
acquisition  of  Pivotal,  which  increases  the size and  profitability  of the
Company and significantly  strengthens our pharmaceutical  research division. We
also successfully resolved the lawsuit brought against our North Point facility,


                                    -- 4 --

which will allow us to  appropriately  focus all of our  attention on operations
and strategic initiatives to enhance long-term shareholder value. The settlement
and  associated  legal  fees,  coupled  with the  costs  related  to the debt we
initially planned to use for the Pivotal acquisition have certainly impacted our
results  for the  period,  but I have no doubt  whatsoever  that the  Company is
stronger today."

One-Time Expenses:

During the third quarter the company spent  $370,000 on legal fees, and $463,000
in a settlement  regarding the medical  malpractice  lawsuit  brought  against a
clinician  who worked for the  company's  North Point Mental  Health  subsidiary
prior to Pioneer's  acquisition of North Point.  As a result of this  situation,
the Company  incurred  $1,031,249  of one-time  expenses  during the nine months
ended March 31, 2004.

The Company also  experienced  higher than normal  interest  expense  during the
quarter  related to the  Company's  initial plan to finance the  acquisition  of
Pivotal  primarily  through debt,  which  resulted in the up-front  expensing of
$114,500 of financing  costs, the amount that would have been amortized over the
term of the  loan.  In order to fund the  acquisition,  it was  determined  that
equity financing was more favorable for the company and its  shareholders.  As a
result of this one-time  expense,  interest  expense and financing costs for the
quarter  increased 72 percent to $219,116.  Exclusive of this one-time  expense,
interest expense for the quarter would have decreased 18 percent to $104,616.

Mr.  Shear  continued,  "We  continued  to see  strong  growth in our  Wellplace
division,  which benefited from the rollout of our services  contract with Wayne
County,  Michigan,  along with implementation of a new smoking cessation program
in Kansas. The Company was recently notified that its contract with the State of
Nebraska will end in May, as it has not been funded by the State for a new term.
Our next  initiative will be the expansion of our facilities and service centers
in Michigan.  While revenue from our pharmaceutical research operations declined
during the  quarter,  we believe  this trend will be  reversed  under the proven
leadership of Dr. Louis Kirby and Mr.  Michael  Colombo and the Pivotal team. We
have elected to  consolidate  our research  operations  under the Pivotal  brand
name,  and we have  confidence  that the team  will  significantly  broaden  our
opportunities  in  the  pharmaceutical  research  segment."

Capital Resources:

Subsequent to the end of the quarter,  the company offered for sale an aggregate
of up to  1,918,196  shares of its Class A Common Stock and warrants to purchase
up to 479,549 shares of Class A Common Stock,  providing  proceeds of $2,110,016
for the use in the acquisition of Pivotal Research Centers,  LLC and for working
capital when it was determined  that debt financing  terms would not be the most
favorable for the Company.

As a result of the financing,  the Company's balance sheet remained strong. Cash
increased from $494,991 to $963,737.  Shareholder's equity increased 11 percent,
to $2.1 million, up from $1.9 million as of June 30, 2003.

The Company continued to reduce its long-term debt obligation. Long-term debt at
the end of March was $2.3  million,  down from $2.9 million as of June 30, 2003.

About  Pioneer  Behavioral  Health

Pioneer  Behavioral  Health's core business  provides  inpatient and  outpatient
behavioral  healthcare  services.  The company contracts with national insurance
companies,  major  transportation  and gaming  companies  to provide  behavioral
health  services.  Pioneer  also  owns and  operates  Wellplace.com,  a  leading
Internet-based   provider  of  behavioral   health  services  to  consumers  and
professionals.   For   more   information,   please   visit   our  web  site  at
www.phc-inc.com or www.haydenir.com.

                                    -- 5 --

This press release may include  forward-looking  statements  that are subject to
risks and uncertainties.  Forward-looking  statements include  information about
possible or assumed future  results of the operations or the  performance of the
company and its future plans and  objectives.  Various  future events or factors
may cause the actual  results to vary  materially  from those  expressed  in any
forward-looking  statements made in this press release (or during the associated
conference call).  These factors and risks are discussed in the company's annual
report on Form  10-KSB  for the years  ended June 30,  2003 and 2002,  copies of
which  were  filed  with the  Securities  and  Exchange  Commission,  and in our
quarterly reports on Form 10-Q filed with the Securities and Exchange Commission
since October 2003.

                                - tables follow -

                                    -- 6 --


                           PHC, INC. AND SUBSIDIARIES
           CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

                                                                    
                                              Three Months Ended            Nine Months Ended
                                                    March 31,                    March 31,
                                           2004                2003      2004              2003
                                       _________________________________________________________
Revenues:
     Patient care, net                 $ 5,583,625    $ 5,341,816     $16,323,589    $15,863,921
     Contract support services             733,411        393,328       2,240,550        943,513
     Pharmaceutical study                  155,152        136,690         500,044        711,957
                                        __________    ____________     ___________    ___________
          Total revenues                 6,472,188      5,871,834      19,064,183     17,519,391
                                        __________    ____________     ___________    ___________
Operating expenses:
     Patient care expenses               3,201,426      2,638,772       9,033,540      7,877,313
     Cost of contract support services     546,667        354,632       1,667,041        855,862
     Provision for doubtful accounts       227,196        196,195       1,113,033        818,652
     Website expenses                       73,191         54,770         219,537        168,345
     Administrative expenses             3,096,804      2,369,205       7,446,760      6,631,883
                                        __________    ____________     ___________    ___________
          Total operating expenses       7,145,284      5,613,574      19,479,911     16,352,055
                                        __________    ____________     ___________    ___________
Income (loss) from operations             (673,096)       258,260        (415,728)     1,167,336
                                        __________    ____________     ___________    ___________
Other expenses:
     Interest income                        20,888          3,119          26,070         10,943
     Other income                           26,059         22,830          77,472         75,206
     Interest expense and financing
          costs                           (219,116)      (127,324)       (466,150)      (419,455)
                                        __________    ____________     ___________    ___________
          Total other expenses            (172,169)      (101,375)       (362,608)      (333,306)
                                        __________    ____________     ___________    ___________

                                    -- 8 --

Income (loss) before provision for income
       taxes                              (845,265)       156,885        (778,336)       834,030
Provision for income taxes                      --         26,074          11,121         36,074
                                        __________    ____________     ___________    ___________

Income (loss) applicable to common
       shareholders  *                 $  (845,265)   $   130,811     $  (789,457)   $   797,956
                                        __________    ____________     ___________    ___________
Income (loss) per share information:

Basic income per common share          $     (0.06)   $      0.01     $     (0.06)   $      0.06
                                        __________    ____________     ___________    ___________
Basic weighted average number of
   shares outstanding                   14,402,988     14,099,929      14,149,261     13,963,138
                                        __________    ____________     ___________    ___________

Diluted income per common share        $     (0.06)   $      0.01     $     (0.06)   $      0.05
                                        __________    ____________     ___________    ___________
Diluted weighted average number of
    shares outstanding                  14,402,988     14,814,570      14,149,261       14,577,540
                                        __________    ____________     ___________    ___________

* Includes one-time expenses of $947,500



                                    -- 9 --


                                               BALANCE SHEET HIGHLIGHTS

                                          March 31st               June 30th

                                            2004                       2003


Cash                                   $    963,737                   $494,991

Total Current Assets                      7,287,710                  6,145,489

Net Property and Equipment                1,296,454                  1,295,113

Total Assets                           $ 10,537,082                $ 9,411,723

Total Current Liabilities                $7,934,987                $ 5,409,312

Total Long Term Debt                        432,301                  2,030,285

Total Liabilities                        $8,390,950                $ 7,476,466

Shareholder's Equity                     $2,146,132                $ 1,935,257

Total Liabilities and Equity           $ 10,537,082                $ 9,411,723





                                    -- 10 --